Short answer: GHK-Cu is two products wearing one name. On the skin, as a cosmetic copper peptide, it has been used for decades and the main reported side effect is irritation. Injected, it is a different story: there are no published human trials, so its side effects have simply not been measured. The most specific risk is the copper itself, which matters a lot for some people and very little for others. Here is how to tell which situation you are reading about.
GHK is not exotic. It is a three-amino-acid fragment (glycine, histidine, lysine) that circulates naturally in human blood, where it grabs copper with very high affinity. Loren Pickart identified it in 1973, and the levels in our blood fall with age. That natural origin is often used to suggest GHK-Cu must be harmless. Being natural in your bloodstream at nanogram levels and being injected at milligram levels are not the same thing, so let’s look at the evidence for each.
Topical vs injected: two different safety files
| Topical (serums, creams) | Injected (research vials) | |
|---|---|---|
| Human exposure history | Decades, millions of users | No published human trials |
| Controlled human studies | A handful, small | None |
| Typical side effects reported | Irritation, redness, dryness | Unknown; anecdotal stinging and redness |
| Regulatory status in Canada | Sold as a cosmetic ingredient | Unauthorized drug |
Most “GHK-Cu is safe” claims online quietly borrow the topical record and apply it to injection. That is the single biggest error in this topic.
What we know about topical GHK-Cu
Copper peptides have been in skincare since the 1990s. Skin absorbs only a small fraction of what is applied, which limits both effects and risks. Reported problems are local: stinging, redness, dryness or a rash, more often at higher concentrations or when combined with strong acids.
The controlled evidence is thinner than the marketing. One randomized trial tested a GHK-Cu product after CO2 laser resurfacing. Blinded evaluators found no significant difference in redness, wrinkles or overall skin quality between groups, even though participants preferred the copper peptide product. Safe enough to use, then, but not proven to do much in that setting. For hair, see what the GHK-Cu and AHK-Cu research really shows.
What we know about injected GHK-Cu
Very little. Animal studies, mostly on wound healing, have not reported major toxicity, and Pickart’s group has published extensive gene-expression work suggesting GHK modulates thousands of genes. But no randomized human trial of injected GHK-Cu has been published.
In the United States, the FDA lists injectable GHK-Cu among bulk drug substances that may present significant safety risks, citing possible immune reactions (immunogenicity) and the lack of human data. That is a regulatory caution, not proof of harm. It does mean that anyone telling you injected GHK-Cu has a “proven safety profile” is overstating the evidence.
Remember: “no side effects reported” and “no side effects” are different statements. For injected GHK-Cu, the first is true because nobody has run the study.
The copper question, with numbers
This is the risk that is specific to GHK-Cu. The complex is roughly 16% copper by weight, so 1 mg of GHK-Cu carries about 0.16 mg of copper. For context, Health Canada’s dietary reference values put adult copper needs around 0.9 mg per day, with a tolerable upper intake of 10 mg per day from all sources.
Two things follow. For most healthy people, the copper in research-scale amounts is small next to that upper limit. But dietary limits assume copper arrives through the gut, which regulates how much is absorbed. Injection bypasses that control. And for anyone whose body cannot handle copper normally, such as people with Wilson disease or significant liver disease, extra copper is a real problem, not a theoretical one.
Stinging, redness, fatigue: the reported effects
| What people report | Evidence level | How to read it |
|---|---|---|
| Stinging, burning on injection | Very common in user reports | Likely related to pH and concentration of the solution. Anecdotal. |
| Redness, bumps at the site | Common in user reports | Local irritation or reaction. Persistent lumps or warmth can signal infection. |
| Skin irritation (topical) | Documented in cosmetic use | The best-established side effect of GHK-Cu. |
| Fatigue, nausea, metallic taste | Forum reports only | Unproven. Sometimes linked to copper, but not measured. |
Health Canada, FDA and WADA
| Health Canada | As a cosmetic ingredient on skin: sold legally. As an injectable: not authorized. GHK-Cu is named in Health Canada’s April 2026 advisory on unauthorized injectable peptides and was among products seized from Canada Peptide in 2025. More in our breakdown of the “research use only” question. |
|---|---|
| FDA (USA) | Not approved as a drug. Injectable GHK-Cu is flagged by the FDA as a bulk substance that may present significant safety risks. |
| WADA (sport) | Not named on the list, but considered prohibited under S0, non-approved substances, according to USADA. |
Bottom line: topical GHK-Cu has a long, mostly uneventful track record. Injected GHK-Cu has no human safety data at all, and its copper content matters for anyone with a copper or liver condition. For skin or hair concerns, a dermatologist can tell you what has real evidence behind it.
See TrueLabs GHK-Cu and its COA →
Frequently asked questions
Cliquez sur une question pour afficher la réponse.
What are the side effects of GHK-Cu?
Topical GHK-Cu can cause skin irritation, redness or dryness. Injected GHK-Cu has no published human trials, so its side effects have not been measured. Stinging and redness at the injection site are commonly reported online but are anecdotal.
Is GHK-Cu safe?
Topical copper peptides have a long record of cosmetic use with mostly mild, local reactions. Injected GHK-Cu has no established human safety profile, and the FDA lists injectable GHK-Cu as a substance that may present significant safety risks.
Can GHK-Cu cause copper toxicity?
GHK-Cu is about 16% copper by weight, so 1 mg contains about 0.16 mg of copper. That is small next to the adult upper limit of 10 mg per day, but injection bypasses the gut’s control of copper absorption, and people with Wilson disease or liver disease are at real risk from extra copper.
Why does GHK-Cu sting?
Stinging is most likely related to the pH and concentration of the reconstituted solution rather than the peptide itself. It is widely reported but has not been studied.
Is GHK-Cu legal in Canada?
GHK-Cu is legal as a cosmetic ingredient in skincare. As an injectable, it is not authorized by Health Canada and is named in its April 2026 advisory on unauthorized peptides.
Is GHK-Cu banned in sport?
It is not named on the WADA list, but USADA considers it prohibited under S0, non-approved substances.
Related reading
- Why is GHK-Cu blue?
- Copper peptides and hair: what the research shows
- GHK-Cu in Canada: research and buying guide
References
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. PMC
- Randomized trial of a topical copper peptide product after CO2 laser resurfacing. PubMed 16847171
- BSCG. GHK-Cu peptide: benefits, safety, legal status and research (summary of FDA and USADA positions). BSCG
- Health Canada. Dietary Reference Intakes tables (copper). Canada.ca
- Health Canada. Think twice before injecting peptides bought online. Public advisory, April 9, 2026. Health Canada
- Health Canada. Advisory RA-77807 (Canada Peptide), August 1, 2025. Recalls and Safety Alerts
All TrueLabs products are sold for in vitro and laboratory research use only. They are not intended for human or veterinary use, and nothing in this article is medical advice. For skin, hair or health concerns, please talk to a doctor or dermatologist.